Opher Caspi
Overview
Explore the profile of Opher Caspi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harel K, Czamanski-Cohen J, Cohen M, Caspi O, Weihs K
Psychooncology
. 2025 Jan;
34(2):e70094.
PMID: 39891317
Objective: As survival rates from breast cancer increase, the post-treatment period poses several challenges, including a high burden of cancer-related symptoms that interfere with quality of life. This study aims...
2.
Harel K, Czamanski-Cohen J, Cohen M, Lane R, Dines M, Caspi O, et al.
Brain Behav Immun
. 2024 Dec;
124():387-396.
PMID: 39674559
Cancer survivors have elevated levels of proinflammatory cytokines, which could be associated with cancer-related symptoms. Given that proinflammatory cytokines heighten negative affect by directly affecting the brain, we explored these...
3.
Bulmash B, Amar M, Ben-Assuli O, Caspi O
J Altern Complement Med
. 2021 May;
27(8):710-712.
PMID: 33979528
No abstract available.
4.
Yerushalmi R, Bargil S, Ber Y, Ozlavo R, Sivan T, Rapson Y, et al.
Carcinogenesis
. 2020 May;
41(10):1395-1401.
PMID: 32458980
Women who carry the BRCA mutation are at high lifetime risk of breast cancer, but there is no consensus regarding an effective and safe chemoprevention strategy. A large body of...
5.
Leader A, Gafter-Gvili A, Benyamini N, Dreyer J, Calvarysky B, Amitai A, et al.
Clin Lymphoma Myeloma Leuk
. 2018 Aug;
18(9):e351-e362.
PMID: 30122203
Background: There are inconsistencies in reports on correlates for nonadherence (NA) to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML). The diagnostic accuracy of subjective adherence measures using electronic...
6.
Leader A, Benyamini N, Gafter-Gvili A, Dreyer J, Calvarysky B, Amitai A, et al.
Clin Lymphoma Myeloma Leuk
. 2018 Jul;
18(11):e449-e461.
PMID: 30030034
Background: Nonadherence to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) has been associated with inferior outcomes. Scarce evidence exists on the effectiveness of adherence-enhancing interventions. The present pilot...
7.
Shalom-Sharabi I, Frenkel M, Caspi O, Bar-Sela G, Toledano M, Samuels N, et al.
Integr Cancer Ther
. 2018 Apr;
17(3):697-706.
PMID: 29607685
Purpose: Integrative oncology (IO) services provide complementary/integrative medicine (CIM) therapies to patients as part of their supportive cancer care. In this study, we examine and compare the structural, operational, financial...
8.
Caspi O
Harefuah
. 2015 May;
154(3):187-91, 211, 210.
PMID: 25962250
Although gratifying, it is somewhat misleading to describe the progress made in recent years in the field of integrative medicine just by counting the number of new programs established. This...
9.
Caspi O, Polak A
Harefuah
. 2013 Aug;
152(7):404-9, 433.
PMID: 23957087
Although the origin of many common modern medicines that are routinely being used nowadays in healthcare is in medicinal plants and fungi, herbal medicine as a standalone profession is no...
10.
Duncan B, Shen K, Zou L, Han T, Lu Z, Zheng H, et al.
Arch Phys Med Rehabil
. 2012 May;
93(5):808-15.
PMID: 22541308
Objective: To compare the outcomes of conventional therapies (physical, occupational, and hydrotherapies) plus acupuncture with those without acupuncture when administered intensely in the management of children with spastic cerebral palsy...